Pooled CRISPR Screening Market - Analysis of Opportunities, Market Share, Growth, Competition, and Forecast through 2030

The Business Research Company

TBRC's Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Report 2026 – Market Size, Trends, And Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, May 19, 2026 /EINPresswire.com/ -- "The pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market has experienced remarkable growth recently, driven by advances in genetic research and gene-editing technologies. As scientific and medical communities continue to explore innovative applications of CRISPR, the market is set to expand significantly in the coming years. Here is an overview of the market’s size, key growth drivers, regional dynamics, and emerging trends.

Rapid Expansion of the Pooled CRISPR Screening Market Size from 2025 to 2030
The CRISPR screening market has seen rapid growth in recent times and is projected to continue on this trajectory. In 2025, the market size is estimated at $1.3 billion, rising to $1.51 billion by 2026, which corresponds to a compound annual growth rate (CAGR) of 15.9%. Looking ahead, the market is expected to expand further to $2.74 billion by 2030, with an accelerated CAGR of 16.1%. The past growth has been fueled by increasing demand for functional genomics, widespread adoption of CRISPR-Cas9 technology, enhanced pharmaceutical research and development, progress in gene-editing tools, and the growth of academic research programs.

Download a free sample of the pooled clustered regularly interspaced short palindromic repeats (crispr) screening market report:
https://www.thebusinessresearchcompany.com/sample_request?id=56373934&type=smp&name=Pooled%20Clustered%20Regularly%20Interspaced%20Short%20Palindromic%20Repeats%20%28CRISPR%29%20Screening%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=May_PR

Forecast Period Growth in the Pooled CRISPR Screening Market Driven by Innovation
The strong growth expected between 2026 and 2030 is attributed to several cutting-edge advancements. These include AI-enabled gene screening, the integration of CRISPR with cloud-based genomics platforms, rising demand for personalized medicine, expansion of biotech infrastructure, and automation of high-throughput screening processes. Key trends anticipated to shape the market involve sophisticated high-throughput screening techniques, the merging of multi-omics data, automated CRISPR workflows, AI-driven identification of gene targets, and real-time functional genomics analysis.

Understanding Pooled CRISPR Screening and Its Role in Gene Editing
Pooled CRISPR screening is a high-throughput genetic technique that employs CRISPR-Cas systems to simultaneously modify or knock out numerous genes across a population of cells. This approach enables researchers to pinpoint genes involved in specific cellular mechanisms, disease pathways, or drug responses by monitoring the effects of targeted genetic alterations within the pooled cell population. It serves as a powerful tool for studying gene function on a broad scale.

View the full pooled clustered regularly interspaced short palindromic repeats (crispr) screening market report:
https://www.thebusinessresearchcompany.com/report/pooled-clustered-regularly-interspaced-short-palindromic-repeats-crispr-screening-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=May_PR

Genetic Disorder Prevalence as a Key Factor Fueling CRISPR Screening Demand
The increasing incidence of genetic disorders is a major factor propelling the growth of the CRISPR screening market. Genetic disorders, which result from inherited or acquired DNA abnormalities, impact normal development, metabolism, and physiological functions. Factors such as advanced parental age, better diagnostic techniques, and extended genetic screening programs have contributed to higher detection rates. Pooled CRISPR screening plays a vital role by offering genome-wide identification of disease-associated genes and regulatory networks. For example, in October 2024, the UK’s Cystic Fibrosis Trust reported an increase in registered cystic fibrosis patients from 11,148 in 2022 to 11,318 in 2023, a growth of about 1.5%. This rise highlights the growing need for CRISPR screening in genetic disorder research.

Increased Research and Development Investments Boosting Market Growth
Another significant driver is the surge in research and development (R&D) investments supporting advancements in real-time genomic data analysis. R&D funding is critical for developing innovative gene-editing tools, refining screening protocols, and enhancing the precision and efficiency of CRISPR-based technologies. Companies are continually investing to keep pace with rapid digital transformations and evolving industry standards. For instance, in 2023, the UK government’s net R&D expenditure increased by 8.2% to £17.4 billion ($22.1 billion) from £16.1 billion ($20.45 billion) in 2022, according to the Office for National Statistics. Such increased spending is expected to continue driving growth in CRISPR screening applications.

North America Leads While Asia-Pacific Shows the Fastest Growth Potential
In terms of regional market dynamics, North America held the largest share of the CRISPR screening market in 2025, benefiting from strong biotech infrastructure and extensive research activities. Meanwhile, the Asia-Pacific region is projected to be the fastest-growing market during the forecast period, driven by expanding healthcare investments and increasing adoption of advanced gene-editing technologies. The market analysis covers key regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a broad view of global developments in this sector.

Browse Through More Reports Similar to the Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market 2026, By The Business Research Company

gastric cancer therapy market report 2026
https://www.thebusinessresearchcompany.com/report/gastric-cancer-therapy-global-market-report

over the counter (otc) drugs market report 2026
https://www.thebusinessresearchcompany.com/report/over-the-counter-otc-drugs-global-market-report

aryl hydrocarbon receptor market report 2026
https://www.thebusinessresearchcompany.com/report/aryl-hydrocarbon-receptor-global-market-report

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.